DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT05671887
- Status
- Recruiting
Conditions
- Bilateral Cancer
- Lung Cancer
- Lung Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Double Lung Transplantation — PROCEDURETo evaluate outcomes among patients who undergo lung transplantation for treatment of a select group of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.
Study Details
This is a prospective observational registration trial for patients who undergo lung transplantation for the treatment of the select groups of medically refractory cancers affecting the lungs alone without extrapulmonary nodal and distant metastasis.
Key Dates
- Start date
- Nov 16, 2022
- Status verified
- Nov 2024
- Primary completion
- Nov 30, 2032
- Completion
- Nov 30, 2032
Study Design
- Enrollment
- 125 participants (estimated)
Arms
- Arm: Cohort A: Primary lung cancers\- Examples include invasive mucinous/non-mucinous non-small cell lung cancers and multifocal carcinomas
- Arm: Cohort B: Metastatic cancers to the lung only\- Examples include germ cell tumors, head \& neck tumors, colorectal tumors, renal cell tumors
- Arm: Cohort C: Respiratory failure with a history of cancer in the last 5 years\- Examples include, but not limited to interstitial lung disease (ILD), pulmonary fibrosis (idiopathic or secondary), advanced chronic obstructive pulmonary disease (COPD), bronchiectasis, emphysema, cystic fibrosis (CF), emphysema due to alpha-1 antitrypsin deficiency, and pulmonary arterial hypertension (PAH)
Primary Outcome Measure
overall survival (OS) rate [ Time Frame: 30-day ]
Central Contacts
- Lung Transplant Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital)312-695-5864
- Liam Il-Young Chung, MD MPH312-472-6245
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital) | Chicago | Illinois | 60611 | Lung Transplant Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital) 312-695-5864 Young Chae, MD MPH MBA Ankit Bharat, MD Rade Tomic, MD |
Find similar trials in Chicago, IL
By condition
By specialty
Related Studies
- A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung CancerPHASE3 · Not Yet Recruiting · Cell>Point LLC · Decatur, Illinois
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung CancerPHASE2/PHASE3 · Recruiting · Canadian Cancer Trials Group · Chicago, Illinois
- Prolonged Air Leak (PAL) Autologous Blood Patch Intervention TrialEnrolling By Invitation · Rush University Medical Center · Chicago, Illinois